Garreau JR - Search Results

1

Delayed adjuvant endocrine therapy is associated with decreased recurrence-free survival following neoadjuvant chemotherapy for breast cancer.

Sutton TL, Patel R, Behrens S, Schwantes I, Fewel C, Gardiner SK, Johnson N, Garreau JR. Sutton TL, et al. Among authors: garreau jr. Am J Surg. 2023 May;225(5):861-865. doi: 10.1016/j.amjsurg.2023.02.020. Epub 2023 Feb 24. Am J Surg. 2023. PMID: 36858865

2

Breast cancer in women under 50: Most are not high risk.

Sutton T, Reilly P, Johnson N, Garreau JR. Sutton T, et al. Among authors: garreau jr. Am J Surg. 2018 May;215(5):848-851. doi: 10.1016/j.amjsurg.2018.01.003. Epub 2018 Jan 11. Am J Surg. 2018. PMID: 29366482

3

Surgical timing following neoadjuvant chemotherapy for breast cancer affects postoperative complication rates.

Sutton TL, Johnson N, Schlitt A, Gardiner SK, Garreau JR. Sutton TL, et al. Among authors: garreau jr. Am J Surg. 2020 May;219(5):741-745. doi: 10.1016/j.amjsurg.2020.02.061. Epub 2020 Mar 10. Am J Surg. 2020. PMID: 32200974

4

Adequate sentinel node harvest is associated with low false negative rate in breast cancer managed with neoadjuvant chemotherapy and targeted axillary dissection.

Sutton TL, Johnson N, Garreau JR. Sutton TL, et al. Among authors: garreau jr. Am J Surg. 2020 May;219(5):851-854. doi: 10.1016/j.amjsurg.2020.03.012. Epub 2020 Mar 10. Am J Surg. 2020. PMID: 32245609

5

Time to surgery following neoadjuvant chemotherapy for breast cancer impacts residual cancer burden, recurrence, and survival.

Sutton TL, Schlitt A, Gardiner SK, Johnson N, Garreau JR. Sutton TL, et al. Among authors: garreau jr. J Surg Oncol. 2020 Dec;122(8):1761-1769. doi: 10.1002/jso.26216. Epub 2020 Oct 30. J Surg Oncol. 2020. PMID: 33125715

6

Loss of HER2-positivity following neoadjuvant targeted therapy for breast cancer is not associated with inferior oncologic outcomes.

Wetzel CL, Sutton TL, Gardiner S, Farinola M, Johnson N, Garreau JR. Wetzel CL, et al. Among authors: garreau jr. J Surg Oncol. 2021 Dec;124(8):1224-1234. doi: 10.1002/jso.26646. Epub 2021 Aug 20. J Surg Oncol. 2021. PMID: 34416025

7

Variation in adoption of skin and nipple sparing mastectomy: An opportunity to enhance patient outcomes.

Wetzel CL, Gardiner SK, Johnson N, Garreau JR, Sutton TL. Wetzel CL, et al. Among authors: garreau jr. Am J Surg. 2022 Aug;224(2):710-715. doi: 10.1016/j.amjsurg.2022.05.020. Epub 2022 May 23. Am J Surg. 2022. PMID: 35659767

8

Axillary reverse lymphatic mapping reduces patient perceived incidence of lymphedema after axillary dissection in breast cancer.

Pasko JL, Garreau J, Carl A, Ansteth M, Glissmeyer M, Johnson N. Pasko JL, et al. Am J Surg. 2015 May;209(5):890-5. doi: 10.1016/j.amjsurg.2015.01.011. Epub 2015 Feb 24. Am J Surg. 2015. PMID: 25796096

9

Use of integrative services is associated with maintenance of work schedule during and after cancer treatment.

Walcott-Sapp S, Johnson N, Garreau J. Walcott-Sapp S, et al. Am J Surg. 2018 May;215(5):892-897. doi: 10.1016/j.amjsurg.2018.02.009. Epub 2018 Feb 13. Am J Surg. 2018. PMID: 29471964

10

Atypical ductal hyperplasia: Clinicopathologic factors are not predictive of upgrade after excisional biopsy.

Sutton T, Farinola M, Johnson N, Garreau JR. Sutton T, et al. Among authors: garreau jr. Am J Surg. 2019 May;217(5):848-850. doi: 10.1016/j.amjsurg.2018.12.020. Epub 2018 Dec 17. Am J Surg. 2019. PMID: 30611396

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters